AlphaGen Therapeutics

AlphaGen Therapeutics is a biopharmaceutical company focused on the discovery, development, manufacturing, and commercialization of innovative targeted radioligand therapies (RLTs). The company leverages a cutting-edge technology platform to develop next-generation alpha radiopharmaceuticals, aiming to address significant unmet medical needs in oncology for patients in China and globally. Founded through an incubation partnership between Eight Roads Ventures China and Professor Cheng Zhen, a leading scientist in radiopharmaceuticals, the company is building an end-to-end supply chain and a robust pipeline of targeted therapies. Their approach includes both internal R&D and strategic collaborations to access novel isotope isolation technologies.